title: Update on the treatment of diabetic foot infections.
abstract: This article brings the practicing clinician up to date on the current concepts regarding the medical treatment of diabetic foot infections. Topics include a review of the Infectious Diseases Society of America Practice Guidelines for the Diagnosis and Treatment of Diabetic Foot Infections and a discussion of newer antibiotics such as linezolid, ertapenem, moxifloxacin, dalbavancin, tigecycline, ceftobiprole and iclaprim.
authors.affiliation: Department of Medicine, New York College of Podiatric Medicine, 1800 Park Avenue, New York, NY 10035, USA. mkosins@nycpm.edu
authors.forename: Mark A
authors.initials: MA
authors.lastname: Kosinski
authors.forename: Warren S
authors.initials: WS
authors.lastname: Joseph
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D017719:Diabetic Foot / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D016106:Methicillin Resistance; D010019:Osteomyelitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D017410:Practice Guidelines as Topic; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents